×

State Medicaid Coverage of Medication-Assisted Addiction Treatment Therapies Is The Focus Of New OPEN MINDS Market Intelligence Report

GETTYSBURG, PA, Aug. 10, 2015 (GLOBE NEWSWIRE) -- OPEN MINDS has published a detailed report focused on State Medicaid coverage of Medication-Assisted Addiction Treatment Therapies in a new OPEN MINDS Market Intelligence Report titled How Are Medication-Assisted Therapies Used In Addiction Treatment? The online resource covers the types of Medication-Assisted Treatments (MAT) available, regulations for opioid dependence administration, and how Medicare and state Medicaid programs cover MAT.

Medicaid programs are not required to cover substance abuse services, and therefore may decide whether or not to cover medication assisted treatments.
States cover medications differently and may place varying restrictions on which medications are covered and preferred. The OPEN MINDS report reviews how the Medicare program covers MAT and provides an informative chart outlining the coverage offered by each state.

"Various studies have demonstrated the effectiveness of MAT – both as a cost saving measure and as a method of reducing relapse and inpatient admissions," explains Monica E. Oss, OPEN MINDS Chief Executive Officer. "This report provides a comprehensive overview of MAT and how it relates to treating substance abuse from the perspective of a health and human service organization serving complex consumers."

The table of contents for this report is as follows:

  1. What Is Medication-Assisted Treatment?
  2. What Types Of Medication-Assisted Treatments Are Available?
  3. What Are Regulations For Opioid Dependence Administration?
  4. How Do State Medicaid Programs Cover MAT?
  5. How Does Medicare Cover MAT?


"Between 2002 and 2013, we have seen a 286% increase in the number of heroin related deaths and between 1999 and 2012 a 400% increase in opioid analgesics related deaths," said Athena Mandros, OPEN MINDS Market Intelligence Manager and author of the recent OPEN MINDS article, If MAT For Addictions Is So Good, Why Aren't More Consumers Using It?. "As an industry, it is critical we look at changing the way our system delivers care to those with opioid dependence – and MAT is an evidence-based option that can make a real difference."

The report, available for instant download through the OPEN MINDS E-Store, can be accessed at https://www.openminds.com/downloads/how-are-medication-assisted-therapies-used-in-addiction-treatment-an-open-minds-market-intelligence-report. It is available at no charge to Premium OPEN MINDS members, or for $495.00 for non-members.

*********************************************************************

OPEN MINDS is a national market intelligence firm specializing in the sectors of the health and human service industry serving individual with complex support needs: mental health; addictions treatment; children & family services; intellectual & developmental disabilities; chronic disease management; long-term care; social services; correctional health care, reentry & diversion; and juvenile justice.

Founded in 1987 and based in Gettysburg, Pennsylvania, the 75+ associates believe by providing the latest market intelligence and management best practices to organizations serving the health and social support needs of the most vulnerable consumers, those organizations will be better able to provide efficient and effective services, learn more at www.openminds.com.

For additional questions and inquiries, please contact Tim Snyder, Vice President, Marketing, OPEN MINDS at 717-334-1329 or openminds@openminds.com.

CONTACT: Tim Snyder Vice President, Marketing 717-334-1329 openminds@openminds.com

Source: Open Minds